SEAS study may link Vytorin, cancer
Today in Munich, Germany, researchers presented all of the data from the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) study to the European Society of Cardiology. The SEAS study roused concern back in July when researchers revealed a possible link between cancer and the Zetia half of Vytorin.
![[ Beasley Allen Law Firm Logo ]](http://www.vytorin-lawyer.com/wp-content/themes/system-unity/images/logo.png)
